Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cyberonics plans PMA (premarket approval) for depression device:

This article was originally published in Clinica

Executive Summary

Cyberonics says it will submit a premarket approval (PMA) application to the US FDA at the end of October for its implantable device for treating depression. The announcement follows successful preliminary talks with the agency. The VNS Therapy device, which stimulates the vagus nerve, in under expedited review and Houston, Texas-based Cyberonics expects the FDA to approve the device within one year. The therapy is aimed at improving symptoms in patients with treatment resistant depression.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel